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Living with stable angina: patients’ pathway and needs
in angina
Ilaria Spoletinia, Roberto Ferrarib and Giuseppe M.C. Rosanoa
Aims There is evidence that stable angina patients may
suffer from emotional disorders that further impair their
quality of life. However, the emotional experience of living
with stable angina from the patient’s perspective still has to
be explored. Thus, the main aim of this study was to explore
patients’ emotional experience of having stable angina and
their reported needs during the pathway from the first
symptoms, through the process of diagnosis, to
management and related lifestyle changes.
Methods A survey was conducted in 75 chronic ischemic
heart disease patients with angina (Brazil, China, Romania,
Russia, and Turkey) using a 75-min, face-to-face in-depth
interview.
Results and Conclusion Patients’ responses highlighted
the need to increase individuals’ awareness on the first
signs and symptoms of the disease. The survey also
showed that chronic stable angina patients need constant
emotional support to overcome stress, anxiety, and
depression. Finally, this study suggests the need to offer
greater space for dialogue with healthcare professionals
to get more comprehensive and ‘patient-friendly’
information.
J Cardiovasc Med 2020, 21:377–382
Keywords: angina, awareness, ischemic heart disease, management,
psychological support
aCentre for Clinical and Basic Research, Department of Medical Sciences,
IRCCS San Raffaele Pisana, Rome and bCardiological University Centre of
Ferrara, University of Ferrara, Maria Cecilia Hospital, GVM Care & Research,
Cotignola (RA), Italy
Correspondence to Ilaria Spoletini, PhD, Centre for Clinical & Basic Research
IRCCS San Raffaele Pisana, via della Pisana, 235, 00163 Rome, Italy
Tel: +39 6 52252409; fax: +39 6 52252465; e-mail: ilaspoletini@gmail.com
Received 28 November 2019 Revised 16 January 2020
Accepted 8 February 2020
Introduction
Angina and ischemic heart disease (IHD) are the leading
causes for death and disability in both sexes.1 The most
frequent, and often the first, manifestation of IHD is
chronic stable angina.2 Angina because of IHD affects
approximately 112 million people in the world.3,4 Nota-
bly, up to 30% of IHD patients with stable angina
continue experiencing symptoms despite treatment.5
Of note, recurrence of angina, impaired exercise capacity,
and quality of life (QoL) remain an issue even after
optimal revascularization. There is evidence that
between 20 and 40% of relapses occur after revasculari-
zation and lead to higher healthcare costs.6,7
Persistent angina symptoms are associated with chronic
anxiety, depression, impaired physical functioning, and
poor QoL, all leading to a striking increase of indirect
costs.8,9 There is evidence that impaired QoL in angina
patients is associated with worse prognosis.10,11
However, little is known about patients’ subjective needs
and emotional experiences during the clinical course of
the disease.
Taking into account these issues, a survey study was
administered to explore the patients’ reported experi-
ence of living with stable angina.
First, the patient’s pathway (from physical and psycho-
logical points of view) from initial symptoms through
diagnosis to management and related lifestyle changes
was explored.
Second, the study aimed to collect patients’ reported
information about their relationship with the healthcare
professionals (HCPs) involved in management, key mile-
stones, and day-to-day challenges.
Third, the survey aimed to explore patients’ awareness
on their disease, the process of seeking help, the degree
of satisfaction with the information sources and possible
gaps in the communication process.
Methods
A sample of 75 patients were enrolled from Brazil, China,
Romania, Russia, and Turkey according to the following
inclusion criteria: both sexes; 50% of sample to be aged
65 years or less; beingmanaged by aHCP for their angina;
both private and public settings; any educational levels;
being not affiliated to a pharma company.
A 75-min, face-to-face in-depth interview was carried out
between April and May 2018. Interviews were conducted
by a research partnership company and their local part-
ners in the relevant countries: Brazil (Exafield), China
(Plamed), Russia (OþK Research), Turkey (Eksen),
Romania (SODA).
nterviews were conducted and audio recorded in the local
language and analyzed in English by native speakers.
The interviews were carried in an anonymous way.
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Interviews consisted of the following sections: introduc-
tion and overall journey with stable angina; personal
information (e.g. age, marital status, etc.); detailed
patient journey; prediagnosis; first time encountering
the symptoms; behavior when symptoms occurred; type
of medical professional contacted for the first time; trig-
gers to look for medical help; emotions during the period;
diagnosis-time of establishing; specialist, healthcare insti-
tution, type of tests, and emotions at knowing the diag-
nosis; information and advice from the healthcare
professionals on the disease; lifestyle; treatment initia-
tion, treatment changes and compliance; percutaneous
coronary intervention (PCI); symptoms, consultation fre-
quency, treatment after the PCI; sources of information.
Before the interviews, patients had to fill-in a 30min
preinterview task-based diary translated into their local
language. The Research Partnership‘s local fieldwork
partners were responsible for translating the answers
into English.
This study follows the methodology of the survey, and is
therefore descriptive. Data are expressed as frequencies
and percentages.
Compliance with ethics guidelines
The interviews were conducted according to the ethical
standards of BHBIA and EphMRA.
Results
Demographic and baseline characteristics
All patients enrolled (n¼ 75) completed the survey.
Demographic and clinical characteristics are shown in
Table 1.
Patients were also stratified according to duration of
stable angina since diagnosis (Table 2). Descriptive data
on patients’ disease history and comorbidities are avail-
able upon request.
Awareness of symptoms
Whenever initial symptoms occurred, 19 of the 75
patients reported to have been scared as they did not
understand what was happening; many patients also felt
frustrated about the impact on their lives.
The most frequently reported symptoms were: chest
pain, shortness of breath, sweating, tiredness. About 56
patients (75%) reported having experienced typical chest
pain-angina, and respectively 19 patients (25%) reported
atypical symptoms. Twenty-six (47%) of the typical
angina patients and 12 (63%) of the patients with atypical
symptoms ignored the symptoms initially, some of them
for months, and were unaware of angina manifestations
before they received the diagnosis, or had limited knowl-
edge about it (SDC Figs. 2-10, http://links.lww.com/
JCM/A241).
If symptoms were more discreet and indistinct, often
patients did not consider them as serious enough to need
medical attention immediately.
For those who did not seek immediate help, it took
between 1 month and years after initial symptoms before
the patients asked for medical help.
Before seeking medical help, the interviewed patients
(who provided an answer) reported having used the
following coping strategies: self-medication (e.g. pain
killers/sedatives) (15 patients); stopping activities/deep-
breathing and waiting for symptoms to pass (18 patients);
avoiding stressful situations/getting upset (3 patients).
The degree of awareness increased if patients had a
family member who was engaged with them.
Initial symptoms started most commonly after an emo-
tional stress (e.g. argument with family member, stuck in
traffic, etc.) or during physical exercise.
Forty-three patients (57%) were diagnosed at the emer-
gency room/hospital and 32 (43%) at the outpatient
setting with the general practitioner playing an important
role in half of the cases.
The diagnosis was perceived by patients as a time of
worry, especially because of its long-term impact, and
patients reported the need to be reassured.
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Table 1 Demographic and clinical characteristics of participants n
U 75
Sex 38 females/37 males
Age Total¼60.3 years old
59.6 Brazil
62.7 China
62.3 Romania
65.9 Russia
51.2 Turkey
Disease duration n¼19 less than 1 year
n¼22 between 1 and 5 years
n¼34 with more than 5 years
Data on patient history and
co-morbiditiesa
n¼42 MI
n¼11 patients 1 month-post PCI
n¼13 post-PCI symptomatic
n¼33 diabetes
n¼17 LVD or HF
HF, heart failure; LVD, left-ventricular dysfunction; MI, myocardial infarction; PCI,
percutaneous coronary intervention. a Patients could belong to more than one
group.
Table 2 Patients’ stratification according to duration of stable angina
Sample Brazil China Romania Russia Turkey Total
Patients diagnosed less than 1 year ago 5 4 1 2 7 19
Patients who first suffered symptoms between 1 and 5 years ago but who were not diagnosed in the last year 5 5 5 5 2 22
Patients who first suffered symptoms over 5 years ago but who were not diagnosed in the last year 5 6 9 8 6 34
Final sample 15 15 15 15 15 75
Among the interviewed patients who gave an answer, 18
reported having had anxiety, 15 having felt scared and
helpless, 12 having been fearful about the future, whereas
only 6 reported avoidance, and only 4 having felt relief at
the moment of diagnosis.
At diagnosis, patients were overall satisfied [n¼ 37 (86%)
out of the 43 patients who provided an answer] with
information provided by the HCPs. The main advice
they got related to lifestyle, diet, treatment but some
wished they had more time to discuss their condition
more deeply especially regarding how to apply these
lifestyle changes.
Consultations with cardiologists occur every 3–6 months,
with an average length of 30min. Although the majority
of patients reported satisfaction with the relationship
with their physicians, 44% expressed the need for longer
discussions with them.
As for unmet needs related to the consultations, four
patients reported the need for more regular appointments
(mainly in Brazil) and the difficulty in scheduling
appointments. Second,10 patients reported the need to
get more time with physicians/more constructive con-
versations – to discuss conditions more and in greater
detail, including the impact on their lives. Third, four
patients reported the need for physicians to consider
more often their emotions (BR, TK min) and spent more
time to listening. Fourth, three patients reported the
need for HCPs to provide more explanations on stable
angina (min esp. CN) – what caused it, how to manage it.
Finally, two patients reported needing multiple sources
of information, for example, leaflets provided by HCPs.
The most common reported sources of information were:
family and friends (38 patients); Internet (31 patients);
TV (24 patients); social media (14 patients).
Treatment
Twenty patients (27%) were taking statins, 50 (67%) had
antiplatelet therapy and only 42 (56%) were taking anti-
anginal drugs at the time of the interview. Of the 61
patients who provided an answer, 45 declared being
highly engaged with their treatments and to believe they
would be helpful in improving their conditions. However,
16 patients reported no engagement with their treat-
ments.
Patients reported that information on treatments mainly
came from physicians. Although the majority of patients
seemed to be content, some wished they had been
provided with more information. For example, 33
(44%) patients pointed out that they needed longer
discussions with the HCPs on the general management.
In general, reported patient knowledge of treatments is
minimal. Very few patients recall being told about the
mode of action or efficacy of their treatments. A minority
would have liked more information on medications, for
example, on how they work, different options, side
effects (CN, TK) and/or felt they did not get the oppor-
tunity to discuss treatment with physician/get replies to
their questions.
Regarding interventional procedures as a treatment
approach, patients who underwent a planned PCI
(n¼ 25) usually had it within 2 weeks after diagnosis
except for patients in Romania, where it took between 4
and 8 months.
Patients reported having little input in taking the deci-
sion, but because of the explanations received from the
HCP, they are usually optimistic about the impact of the
procedure on their condition.
Among the 11 patients who had undergone PCI less than
1mol/l before the interview, 6 reported encountering
symptoms after the procedure. The same patients did
not seem to be bothered and did not appear, therefore, to
be aware that it might be a problem.
In general, out of the 75 patients, 70 did not monitor
angina symptoms on a regular basis.
Lifestyle changes
Patients’ answers indicate that lifestyle adjustments had
the following meanings/implications: not being able to
live their lives fully; restricting themselves to less stren-
uous physical activity; avoiding strong efforts and stress-
ful situations; reducing/stopping smoking (felt to be most
difficult change: 45% of the patients pointed to finding it
difficult to stop smoking and, for those who stopped, the
main driver was fear of the consequences on their health
condition); less socializing/going out; giving-up/reducing
work; struggling to stick to dietary changes; feeling it to
be a challenge in social situations; other family not
accepting dietary changes.
The majority of patients reported following HCPs’
advice; however, many stated that they struggled with
lifestyle changes. Overall, lifestyle changes were pointed
out to have brought a negative emotional impact in their
life by the majority of patients.
Living with stable angina
Patients’ reported main challenges are ‘disease emotional
impact’ and ‘dealing with a restricted lifestyle’.
As for emotional impact, only seven patients claimed to
be content with their lives/not frustrated with the disease.
Thirty-seven patients reported anxiety and fear; uncer-
tainty (i.e. never knowing when an attack may happen);
living in fear; worried about dying [more than myocardial
infarction (MI)]. Of note, anxiety is not only related to the
moments of occurrence of symptoms (only 16 patients
pointed out being worried only when symptoms occur)
but it is constant within the course of the disease. The
severity of symptoms appears to have a larger influence
on the disease perception rather than its duration.
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The majority of the patients reported trying to stick to
their ‘previous’/’normal’ lifestyle and to limit the impact
of the condition.
Yet although patients try to live an ‘unrestricted’/’normal’
life, they report frustration; increased boredom and lone-
liness; reduced activity/restricted lifestyle; they are
unable to go out and socialize as much as would like
to; unable to exercise regularly or strenuously; unable to
work. These implications get more tangible with time,
being more prevalent in older patients with a longer time
since diagnosis.
Financial problems are reported by the majority of the
participants. Cost of treatment is reported as a problem
and is exacerbated by the inability to work. Some patients
stated that social services provide little support.
Also, the overall emotional burden of the disease does not
seem to alleviate over time.
Family and friends are reported as the main source of
support for themajority of patients. Aminority of patients
stated they use sources of information other than
their HCPs.
Discussion
The main result of the survey indicates the need to
increase patients’ awareness of the signs and symptoms
of stable angina. The need to increase the common
awareness about the disease and first symptoms is sug-
gested by the high percentage (more than half) of
patients stating they were completely unaware of what
stable angina was before diagnosis, and this might have
delayed a timely diagnosis and earlier beginning of
treatment. This result is in line with existing data dem-
onstrating that low disease awareness is associated with
higher rates of undiagnosed angina.12,13
A better awareness of the triggers for angina (behavioral
factors, stressors, etc.) may be, therefore, helpful. Com-
mon misconceptions may cause patients to avoid these
triggers, which could lead to de-conditioning, worsening
angina and low mood.14 HCPs should be more aware of
the factors that could hinder or stimulate healthy life-
style changes as well.
Patients reported that barriers of healthy behaviors include
lack of time (because of family, household and occupa-
tional responsibilities), access issues (to transport, facilities
and resources), financial costs, entrenched attitudes and
behaviors, restrictions in the physical environment.
Reported facilitators include a focus on enjoyment,
health benefits including healthy aging, social support,
clear messages, and integration of behaviors into lifestyle.
These data are consistent with existing literature.15
The recognition of these barriers can help HCPs to tailor
intervention and treatment around each individual
patient. This is an issue related to the type and
organization of healthcare services provided around dif-
ferent healthcare systems. In spite of the differences,
there is one common pattern: patients get more informa-
tion from family, friends, social networks and mass-
media, rather than from their treating doctor or another
HCP. They seem not to be aware of the mode of action
and potential side effects of the treatment they get.
Among those who underwent an interventional proce-
dure, very few patients mentioned being informed about
potential implications of the procedure before or after.
Another main result of the survey is that out of the 75
patients, 70 did notmonitor angina symptoms on a regular
basis. The need for constant monitoring of the symptoms
may be life-saving and is strongly related to the patient’s
disease awareness.16 Patients’ answers suggest that HCPs
should offer greater dialogue, providing more compre-
hensive and ‘patient-friendly’ information. This may
allow patients to better understand their condition both
from physical and emotional points of view and to follow
symptoms over time.
In particular, the results show that stable angina patients
in our sample need more psychological support to over-
come stress, anxiety, and depression. Such emotional
support may help patients to change lifestyles, monitor
conditions, and to be compliant with treatments and
check-ups over time. These results are in line with
studies in patients with IHD, showing that depressive
symptoms are strongly associated with poor patient-
reported health status, including symptom burden, phys-
ical limitation, poor QoL and worse prognosis.17,18
Depression is related to behavioral risk factors, such as
poor adherence to medication, diet, exercise and smoking
cessation.19 Similarly, anxiety is a risk factor for worse
prognosis, MI or death among patients with IHD.20
Management of psychosocial risk factors and implemen-
tation of educational interventions are therefore pivotal
in angina patients, as recommended by current guide-
lines.21 Consistently, cognitive behavioral programs and
dedicated angina plan management programs have been
shown to improve patients’ awareness, motivation, adher-
ence to lifestyle changes and treatment and to improve
patients’ satisfaction and quality of life.22–24 Of note,
these programs should contain psychotherapy, as it has
demonstrated short-term and long-term benefits in
improving symptoms, QoL and well being, and is related
to better outcomes.25–27
Along with lifestyle changes, patients’ involvement in the
diseasemanagement and follow-up is an important part of
the treatment in order to motivate them to be more
adherent to the treatment.
Our survey suggests very low engagement of patients
regarding the monitoring of their angina symptoms. This
might be associated with low adherence to therapy along
with inadequate evaluation of the current state of the
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patients during the routine check-up visits, and respec-
tively, not adequate treatment and symptom control.
Of note, half of the patients who had undergone PCI but
encountered symptoms did not report being worried, and
neither had they shared with their treating doctor. Cur-
rent data demonstrate that adherence to treatment in
IHD is poor (about 40–75%) and is related to worse
prognosis.28–30 Also, low recognition of symptoms by
physicians is related to less aggressive treatment escala-
tion and consequent poorer angina control.31–33
Our survey suggests that the most suitable and crucial
time for treatment adjustment is the period immediately
after the diagnosis, when the patient feels more vulnera-
ble and trusts the physician the most. Emotional states
and needs during a patient’s pathway are shown in Fig. 1.
Monitoring tools like diaries or electronic applications/
programs might help patients to follow the symptoms and
proactively contact physicians in order to request timely
treatment adjustment.34,35
In conclusion, this survey highlights the need to educate
patients to recognize and understand their disease in order
to be involved in themanagement and collaboratewith the
HCPs, who – in turn – are asked to provide listening, in-
depth information and emotional support. As aforemen-
tioned, increasing awareness may be beneficial in terms of
seeking help sooner, and therefore to get an early diagno-
sis.
Study limitations must be taken into account.
First, sample size is small and cannot be representative of
the population. As such, results cannot be generalized.
Second, because of the methodology of the survey, con-
founding factors and interview related-biases may lead to
overestimating or underestimating the results.
Third, different healthcare systems and cultures because
of territorial differences and cultural backgrounds may
further confound the results.
Finally, not all patients were asked all the questions of
the survey, which additionally makes drawing quantita-
tive conclusions difficult.
Thus, our findings should be considered as purely
descriptive and preliminary.
However, these results may be suggestive of relevant
management implications regarding angina patients’
needs before and after the diagnosis, highlighting the
importance of performing further studies on this topic.
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Fig. 1
«At that time, perhaps, when 
it appeared, I didn’t think too 
much about it. Didn’t think it 
was a heart problem» 
«The changes are not 
good…it would be nice to 
have a change that brings 
me happiness. Stop 
smoking, can’t eat nice 
things, cut sugar, salt» 
Lack of awareness 
«I was getting a bit worried 
because I was feeling a 
strong shortness of breath» 
Concern 
«We kind of knew it was 
something with the heart… I 
thought it could be an 
infarction» 
Anxiety 
«We are always worried 
about another infarction, 
there is always that worry» 
«When I heard that my heart 
was damaged, I thought that 
this was the end» 
Fear 
«I felt astonished (because 
the doctor told me I had had 
a myocardial infarction but I 
hadn’t noticed it)» 
Shock 
«I trust the doctor when he’s 
prescribing me pills» 
«My approach is if a 
professional gives you an 
advice, you should follow it» 
«As the months passed, I 
recovered and became 
stronger, feeling better» 
Relief 
Frustration/sadness 
        First symptoms                                Diagnosis/Treatment                               Life with condition  
Emotional states and needs during patient’s pathway.
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